CINECA IRIS Institutional Research Information System

SAPINO, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.083
AS - Asia 15.633
EU - Europa 14.545
SA - Sud America 2.073
AF - Africa 432
OC - Oceania 227
Continente sconosciuto - Info sul continente non disponibili 26
Totale 58.019
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.394
SG - Singapore 5.317
CN - Cina 5.226
IT - Italia 3.648
BR - Brasile 1.628
DE - Germania 1.585
VN - Vietnam 1.562
FR - Francia 1.430
IE - Irlanda 1.420
SE - Svezia 1.177
FI - Finlandia 1.051
GB - Regno Unito 1.024
UA - Ucraina 770
KR - Corea 724
IN - India 539
AT - Austria 514
PL - Polonia 503
HK - Hong Kong 486
JP - Giappone 476
CA - Canada 466
NL - Olanda 276
ES - Italia 265
AU - Australia 217
ID - Indonesia 217
TR - Turchia 161
MX - Messico 146
IQ - Iraq 140
AR - Argentina 136
BD - Bangladesh 128
BE - Belgio 124
RU - Federazione Russa 123
DK - Danimarca 114
TW - Taiwan 96
CH - Svizzera 93
ZA - Sudafrica 88
SN - Senegal 78
EC - Ecuador 69
TH - Thailandia 68
RO - Romania 63
CO - Colombia 61
EG - Egitto 57
PK - Pakistan 56
PT - Portogallo 55
UZ - Uzbekistan 50
IR - Iran 49
CZ - Repubblica Ceca 48
IL - Israele 48
CL - Cile 45
SA - Arabia Saudita 44
MA - Marocco 42
GR - Grecia 41
HU - Ungheria 39
NO - Norvegia 38
PE - Perù 38
VE - Venezuela 37
PH - Filippine 31
TN - Tunisia 30
JO - Giordania 29
PY - Paraguay 29
KE - Kenya 28
NG - Nigeria 27
MY - Malesia 24
LT - Lituania 23
AE - Emirati Arabi Uniti 22
NP - Nepal 21
LB - Libano 16
AZ - Azerbaigian 15
BO - Bolivia 14
CR - Costa Rica 14
UY - Uruguay 14
BG - Bulgaria 13
EU - Europa 13
MK - Macedonia 12
QA - Qatar 12
RS - Serbia 12
KZ - Kazakistan 11
BA - Bosnia-Erzegovina 10
DZ - Algeria 10
HR - Croazia 10
SI - Slovenia 10
SK - Slovacchia (Repubblica Slovacca) 10
BY - Bielorussia 9
JM - Giamaica 9
NZ - Nuova Zelanda 9
AM - Armenia 8
CI - Costa d'Avorio 8
DO - Repubblica Dominicana 8
ET - Etiopia 8
KG - Kirghizistan 8
LV - Lettonia 8
MU - Mauritius 8
PA - Panama 8
UG - Uganda 8
BH - Bahrain 7
EE - Estonia 7
HN - Honduras 7
OM - Oman 7
AL - Albania 6
CG - Congo 6
GT - Guatemala 6
Totale 57.895
Salva come PNG Salva come JPEG
Città #
Singapore 2.884
Beijing 2.190
Chandler 2.056
Ashburn 1.781
Dublin 1.358
Fairfield 1.290
Santa Clara 1.263
Ann Arbor 1.144
San Jose 1.133
Houston 1.098
Woodbridge 662
Torino 647
Dearborn 596
Wilmington 560
Jacksonville 555
Seattle 524
Villeurbanne 493
Medford 467
Dallas 457
Vienna 448
Cambridge 430
The Dalles 426
Princeton 412
Warsaw 403
Nyköping 396
Columbus 394
Ho Chi Minh City 379
Hong Kong 368
Lauterbourg 363
Los Angeles 346
Hanoi 331
Turin 330
Pisa 313
Helsinki 307
Milan 306
Munich 267
Buffalo 251
Redwood City 250
Hefei 247
New York 236
Seoul 230
Shanghai 223
Dong Ket 219
Guangzhou 210
Tokyo 180
São Paulo 172
Jakarta 170
Boardman 169
Toronto 166
Menlo Park 152
Nanjing 149
Council Bluffs 147
Boston 146
Fremont 141
Hangzhou 136
London 114
Bengaluru 101
Rome 98
San Diego 94
Frankfurt am Main 93
Nuremberg 91
Phoenix 89
Washington 88
Verona 86
Orem 81
Turku 80
Chicago 76
Chengdu 75
Redondo Beach 71
Brussels 69
Pune 68
Amsterdam 66
Norwalk 66
Rio de Janeiro 64
Wuhan 64
Jinan 60
Silver Spring 60
Montreal 59
Paris 57
Lappeenranta 56
Kunming 55
Zhengzhou 55
Da Nang 48
Taipei 48
Chennai 47
Fuzhou 46
Mumbai 45
Belo Horizonte 44
Düsseldorf 44
Falls Church 44
Sydney 44
Atlanta 42
Mexico City 42
Lachine 41
Baghdad 40
Chongqing 40
Naples 39
Changsha 38
Haiphong 38
Johannesburg 37
Totale 33.774
Salva come PNG Salva come JPEG
Nome #
PARP Inhibitors in Ovarian Cancer 2.915
A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer 974
Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer 813
Beneficial behavioural effects of IBD therapy and gluten/casein-free diet in an Italian cohort of patients with autistic enterocolitis followed over one year 798
Autistic enterocolitis: confirmation of a new inflammatory bowel disease in an Italian cohort of patients 617
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells 461
Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values 420
MammaPrint Molecular Diagnostics on Formalin-Fixed, Paraffin-Embedded Tissue 391
Reliability of Whole Sentinel Lymph Node Analysis by One-Step Nucleic Acid Amplification for Intraoperative Diagnosis of Breast Cancer Metastases 371
Comparison of Anti-Estrogen Receptor Antibodies SP1, 6F11, and 1D5 in Breast Cancer: Lower 1D5 Sensitivity but Questionable Clinical Implications 360
Personalized therapeutic strategies in HER2-driven gastric cancer 359
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts 358
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 349
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 348
Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma. 347
Abstract P6-08-12: DSCAM-AS1, a breast cancer specific and Estrogen receptor α-dependent long noncoding RNA, is a key component of the pathway controlling cell growth and migration 337
A "Weighted" Fluorescence In Situ Hybridization Strengthens the Favorable Prognostic Value of 1p/19q Codeletion in Pure and Mixed Oligodendroglial Tumors. 336
Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples 324
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis. 323
Comparative diagnostic and prognostic performances of the hematoxylin-eosin and phospho-histone H3 mitotic count and Ki-67 index in adrenocortical carcinoma 316
Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy. 301
The Rho GTPase Rnd1 suppresses mammary tumorigenesis and EMT by restraining Ras-MAPK signalling 296
SF3B1mutations constitute a novel therapeutic target in breast cancer 290
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond 284
High USP6NL levels in breast cancer sustain chronic AKT phosphorylation and GLUT1 stability fueling aerobic glycolysis 281
THE EXPRESSION OF LINE1-MET CHIMERIC TRANSCRIPT IDENTIFIES A SUBGROUP OF AGGRESSIVE BREAST CANCERS 280
A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer 279
Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up 278
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives 272
Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role? 266
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 260
Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: Final results of a prospective phase II study 260
Androgen receptor status predicts development of brain metastases in ovarian cancers 258
miR-221/222 control luminal breast cancer tumor progression by regulating different targets 249
HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast 246
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. 246
Oxytocin synthesis within the normal and neoplastic breast: first evidence of a local peptide source 245
The diagnosis of inflammatory bowel disease is often unsupported in clinical practice 241
Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis 237
FOXA1 and AR in invasive breast cancer: New findings on their co-expression and impact on prognosis in ER-positive patients 237
The influence of tissue ischemia time on RNA integrity and patient-derived xenografts (PDX) engraftment rate in a non-small cell lung cancer (NSCLC) Biobank 235
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function 233
Cancer of unknown primary stem-like cells model multi-organ metastasis and unveil liability to MEK inhibition 230
Meningeal carcinomatosis underdiagnosis and overestimation: Incidence in a large consecutive and unselected population of breast cancer patients 229
Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases 229
Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes 228
Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues 227
The expression of growth hormone releasing hormone (GHRH) and its receptors in breast carcinomas with apocrine differentiation - further evidence of the presence of a GHRH pathway in these tumors 226
Utilility of flow cytometry as ancillary study to improve the cytologic diagnosis of thyroid lymphomas 224
Sparsely-connected autoencoder (SCA) for single cell RNAseq data mining 224
Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro 222
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines. 218
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 217
Flexible Lab-Tailored Cut-Offs for Suitability of Formalin-Fixed Tumor Samples for Diagnostic Mutational Analyses 215
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer 212
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 212
A collection of primary tissue cultures of tumors from vacuum packed and cooled surgical specimens: a feasibility study 211
Are Breast Cancer Molecular Classes Predictive of Survival in Patients with Long Follow-Up? 210
The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients 210
Relevance of multiple basin drainage and primary histologic regression in prognosis of trunk melanoma patients with negative sentinel lymph nodes. 210
Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues 207
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling 205
Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells. 202
Tamoxifen treatment of breast cancer cells: Impact on Hedgehog/GLI1 signaling 202
A rare case of breast cancer showing distinct TTF-1 nuclear expression: small cell carcinoma or not? 201
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study 201
The role of the AR/ER ratio in ER-positive breast cancer patients 195
Glycerolized reticular dermis as a new human acellular dermal matrix: An exploratory study 195
[Tumor samples as a tool for large-scale monitoring of antigen-specific lymphocytes in gastric and colorectal neoplasms] 194
Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer. 192
“To Be or Not to Be in a Good Shape”: Diagnostic and Clinical Value of Nuclear Shape Irregularities in Thyroid and Breast Cancer 191
Sviluppo pre-clinico di una nuova matrice dermica acellulare di derivazione umana per la ricostruzione mammaria post oncologica 191
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles 189
Colesterolo ossidato e induzione del recettore scavenger CD36 188
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis 187
ASPM and CITK regulate spindle orientation by affecting the dynamics of astral microtubules 183
The perfect pathology report after neoadjuvant therapy 182
Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study 181
Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene 181
A simple and reproducible prognostic index in luminal ER-positive breast cancers. 181
DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3′-End Usage 181
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial 180
Efficiency of a Preoperative Axillary Ultrasound and Fine-Needle Aspiration Cytology to Detect Patients with Extensive Axillary Lymph Node Involvement 180
A tissue quality index: an intrinsic control for measurement of effects of preanalytical variables on FFPE tissue 179
The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas 179
Formalin fixation at low temperature better preserves nucleic acid integrity. 178
A combined glucagonoma and VIPoma syndrome. First pathologic and clinical report. 177
Integration of Ki-67 index into AJCC 2018 staging provides additional prognostic information in breast tumours candidate for genomic profiling 177
Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report 176
CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples 175
Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort 174
Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway. 173
Epidermal Growth Factor Receptor Gene in Primary Tumor and Metastatic Sites from Non-small Cell Lung Cancer. J Thorac Oncol. 2009 Apr 29 172
A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer 171
Clinico-pathologic features of primary melanoma and sentinel lymph node predictive for non-sentinel lymph node involvement and overall survival in melanoma patients: A single centre observational cohort study. 171
A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine 171
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer 170
International expert consensus on primary systemic therapy in the management of early breast cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013) 169
Do Chromosome 17 Centromere Copy Numbers Predict Polysomy? A Fluorescence In Situ Hybridization and Microarray-Based CGH Analysis. 168
Contrast enhanced ultrasound in atherosclerotic carotid artery disease. 168
Totale 28.582
Salva come PNG Salva come JPEG
Categoria #
all - tutte 173.218
article - articoli 0
book - libri 0
conference - conferenze 11.142
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.360
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.037 0 0 0 0 0 0 0 0 0 0 316 721
2021/20225.430 291 309 318 440 316 311 441 388 259 352 998 1.007
2022/20236.737 684 548 206 559 647 1.571 539 474 715 182 374 238
2023/20243.690 422 581 218 246 255 402 179 245 56 270 314 502
2024/20258.612 149 431 372 738 1.923 616 328 510 1.018 636 639 1.252
2025/202614.227 1.564 904 1.072 1.905 1.659 964 2.423 749 1.496 1.176 315 0
Totale 59.403